<html xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops" xmlns:m="http://www.w3.org/1998/Math/MathML" xmlns:svg="http://www.w3.org/2000/svg" lang="en" xml:lang="en">
<head>
<title>Chapter 23 Review in Chapter 23 Cancer Genetics</title>
<meta charset="utf-8"/>
<meta content="final" name="process"/>
<meta content="3.1" name="schema"/>
<link href="../styles/pie_9781319216801.css" rel="stylesheet" type="text/css"/>
<meta content="urn:uuid:1df703a4-880e-4fb4-a16f-bd0ab0744194" name="Adept.expected.resource"/>
</head>
<body class="bodymatter" epub:type="bodymatter">
<section class="end-of-section" id="ben_9781319297145_PAZfhv9Aau">
<header id="ben_9781319297145_kz46LbuB31"><h2 class="title" epub:type="title" id="ben_9781319297145_B96LfhFKDF">Chapter 23 Review</h2></header>
<section class="summary" id="ben_9781319297145_5bWo4QuQt3">
<header id="ben_9781319297145_EGh6omtmVq"><h3 class="title cap v1" epub:type="title" id="ben_9781319297145_sy6Glg4Nzz">Chapter summary</h3></header>
<aside aria-label="Learning Objective" class="learning-objectives c3 main-flow v5" epub:type="learning-objectives" id="ben_9781319297145_qYw4ZIcgCv" title="Learning Objective">
<p class="noindent" id="ben_9781319297145_geIAXurAWt"><strong class="important" id="ben_9781319297145_nSpNN6EPCn">Section 23.1 Learning Objective:</strong> Be able to explain how cancer is a genetic disease, in spite of the fact that most cancers are not inherited.</p>
</aside>
<ul class="ul-square" id="ben_9781319297145_lgRtdgJNGf">
<li id="ben_9781319297145_KNkZJOq6jr">Cancer is fundamentally a genetic disease, arising from somatic mutations in multiple genes that affect cell division and proliferation. If one or more mutations are inherited, then fewer additional mutations are required for cancer to develop.</li>
<li id="ben_9781319297145_o4rGM88jQs">A mutation that allows a cell to divide rapidly provides the cell with a growth advantage; that cell gives rise to a clone of cells having the same mutation. Within this clone, other mutations may occur that provide additional growth advantages; cells with these additional mutations become dominant in the clone. In this way, the clone evolves.</li>
<li id="ben_9781319297145_DWdOJAXPXg">Environmental factors play an important role in the development of many cancers by increasing the rate of somatic mutations.</li>
</ul>
<aside aria-label="Learning Objective" class="learning-objectives c3 main-flow v5" epub:type="learning-objectives" id="ben_9781319297145_lethi97ZDy" title="Learning Objective">
<p class="noindent" id="ben_9781319297145_g86LyRpKgE"><strong class="important" id="ben_9781319297145_H0wNbna6PJ">Section 23.2 Learning Objective:</strong> Be able to summarize the different types of genes that contribute to cancer.</p>
</aside>
<ul class="ul-square" id="ben_9781319297145_raJCFKaJXc">
<li id="ben_9781319297145_AJfSM5q2Ps">Oncogenes are dominant-acting mutated copies of normal genes (proto-oncogenes) that stimulate cell division. Tumor-suppressor genes normally inhibit cell division; recessive mutations in these genes may contribute to cancer. Sometimes the mutation of a single copy of a tumor-suppressor gene is sufficient to cause cancer, a phenomenon known as haploinsufficiency.</li>
<li id="ben_9781319297145_KM8S9VifFv">The cell cycle is controlled by cyclins and cyclin-dependent kinases. Mutations in genes that control progression through the cell cycle are often associated with cancer.</li>
<li id="ben_9781319297145_zBJuHFZ3Fo">Signal-transduction pathways conduct external signals that bring about intracellular responses. These pathways consist of a series of proteins that are activated and inactivated in a cascade of reactions. Mutations in the components of signal-transduction pathways can disrupt the cell cycle and may contribute to cancer.</li>
<li id="ben_9781319297145_gfnEEykdBG">Defects in DNA-repair genes often increase the overall mutation rate of other genes, leading to defects in proto-oncogenes and tumor-suppressor genes, which can contribute to cancer progression.</li>
<li id="ben_9781319297145_xHQXyfCq3k">Mutations in sequences that regulate telomerase allow cells to divide indefinitely, contributing to cancer progression.</li>
<li id="ben_9781319297145_1vE2dyzlLH">Tumor progression is also affected by mutations in genes that promote vascularization and the spread of tumors.</li>
<li id="ben_9781319297145_FWX0L5Z4Oa">Many tumor cells exhibit a widespread reduction in the expression of many miRNAs, suggesting that a reduction in miRNA control of gene expression may play a role in tumor progression.</li>
</ul>
<aside aria-label="Learning Objective" class="learning-objectives c3 main-flow v5" epub:type="learning-objectives" id="ben_9781319297145_aEeyxrllv2" title="Learning Objective">
<p class="noindent" id="ben_9781319297145_D8AUWlbU0F"><strong class="important" id="ben_9781319297145_zy2tBbkpM3">Section 23.3 Learning Objective:</strong> Be able to explain how epigenetic changes contribute to cancer.</p>
</aside>
<ul class="ul-square" id="ben_9781319297145_P7csJXRF4l">
<li id="ben_9781319297145_NNpjE6VCE0">Epigenetic changes in chromatin structure, including DNA methylation and histone modification, are often associated with cancer.</li>
</ul>
<aside aria-label="Learning Objective" class="learning-objectives c3 main-flow v5" epub:type="learning-objectives" id="ben_9781319297145_uEDJbcbkxW" title="Learning Objective">
<p class="noindent" id="ben_9781319297145_Hv92M5wIKz"><span aria-label="726" epub:type="pagebreak" id="page726" role="doc-pagebreak" title="726"/><strong class="important" id="ben_9781319297145_35qfrmIjp5">Section 23.4 Learning Objective:</strong> Be able to outline the sequential mutations in colon cells that lead to colorectal cancer.</p>
</aside>
<ul class="ul-square" id="ben_9781319297145_Phlm8L43Q7">
<li id="ben_9781319297145_m7HHdRdW79">Colorectal cancer offers a model system for understanding tumor progression in humans. Initial mutations stimulate cell division, leading to a small benign polyp. Additional mutations allow the polyp to enlarge, invade the muscle layer of the gut, and eventually spread to other sites. Mutations in particular genes affect different stages of this progression.</li>
</ul>
<aside aria-label="Learning Objective" class="learning-objectives c3 main-flow v5" epub:type="learning-objectives" id="ben_9781319297145_9NsFwYNXRp" title="Learning Objective">
<p class="noindent" id="ben_9781319297145_3rv2H0KnuA"><strong class="important" id="ben_9781319297145_A2rdMvXiB9">Section 23.5 Learning Objective:</strong> Be able to describe different types of changes in chromosome number and structure that contribute to some types of cancer.</p>
</aside>
<ul class="ul-square" id="ben_9781319297145_IlMQvBpgpJ">
<li id="ben_9781319297145_yGL1DucfAN">Some cancers are associated with specific chromosome mutations, including chromosome deletions, inversions, and translocations. Deletions may cause cancer by removing or disrupting genes that suppress tumors; inversions and translocations may break tumor-suppressing genes, or they may move genes to positions next to different regulatory sequences, which alter their expression.</li>
<li id="ben_9781319297145_Hq268GWPsA">Mutations in some genes cause or allow chromosomes to segregate improperly, leading to aneuploidy that can contribute to cancer.</li>
</ul>
<aside aria-label="Learning Objective" class="learning-objectives c3 main-flow v5" epub:type="learning-objectives" id="ben_9781319297145_B5Vihhff7F" title="Learning Objective">
<p class="noindent" id="ben_9781319297145_b4xkCuR09S"><strong class="important" id="ben_9781319297145_Tiio1RSfio">Section 23.6 Learning Objective:</strong> Be able to explain how viruses can cause cancer.</p>
</aside>
<ul class="ul-square" id="ben_9781319297145_f9ooI3k3kV">
<li id="ben_9781319297145_OxIvcdsi4d">Viruses are associated with some cancers; they contribute to cell proliferation by mutating or rearranging host genes or by altering the expression of host genes.</li>
</ul>
</section>
<section class="example c3 main-flow" id="ben_9781319297145_pwf9hSn7QZ" role="doc-example">
<header id="ben_9781319297145_YzxjZBgJb8"><h3 class="title cap v3" epub:type="title" id="ben_9781319297145_JnfNDWamLo">Worked problem</h3></header>
<p class="noindent" id="ben_9781319297145_YaKEyjtOHp">In some cancer cells, a specific gene has been duplicated many times. Is this gene likely to be an oncogene or a tumor-suppressor gene? Explain your reasoning.</p>
<section class="subsect1" id="ben_9781319297145_gMNUwPAY5b">
<header id="ben_9781319297145_xjGv4CQ25U"><h4 class="level1 v3" id="ben_9781319297145_iAW1Aooskg"><img alt="" aria-hidden="true" class="decorative size-med inline" id="ben_9781319297145_H1BmswaUQo" role="presentation" src="../images/piercegenetics7e_01_PG_21.png"/> Solution Strategy</h4></header>
<p class="noindent" id="ben_9781319297145_WLRare3Oaw"><strong class="important" id="ben_9781319297145_21jnGfqlUI">What information is required in your answer to the problem?</strong></p>
<p class="noindent" id="ben_9781319297145_0Heo35hUD7">Whether the duplicated gene is likely to be an oncogene or a tumor-suppressor gene, and why.</p>
<p class="noindent" id="ben_9781319297145_1vLgx7ilaV"><strong class="important" id="ben_9781319297145_V9SoNghOfM">What information is provided to solve the problem?</strong></p>
<p class="noindent" id="ben_9781319297145_GpAIYP73GV">In cancer cells, the gene has been duplicated many times.</p>
<p class="noindent" id="ben_9781319297145_wILD47PCq9"><strong class="important" id="ben_9781319297145_xEKynqppbn">For help with this problem, review:</strong></p>
<p class="noindent" id="ben_9781319297145_o3fq0cvDSh">Oncogenes and Tumor-Suppressor Genes in <a class="crossref" href="pie_9781319216801_ch23_03.xhtml#ben_9781319297145_2NV3AY3MA4" id="ben_9781319297145_APfPYMYPUg">Section 23.2</a>.</p>
</section>
<section class="subsect1" id="ben_9781319297145_0eYFPBeBU7">
<header id="ben_9781319297145_0hsS733Vcs"><h4 class="level1 v3" id="ben_9781319297145_bLkI8iZv9b"><img alt="" aria-hidden="true" class="decorative size-med inline" id="ben_9781319297145_295uXJF9bZ" role="presentation" src="../images/piercegenetics7e_01_PG_21.png"/> Solution Steps</h4></header>
<p class="noindent" id="ben_9781319297145_ytikRSXWhv">The gene is likely to be an oncogene. Oncogenes stimulate cell proliferation and act in a dominant manner. Therefore, extra copies of an oncogene will result in cell proliferation and cancer. Tumor-suppressor genes, on the other hand, suppress cell proliferation and act in a recessive manner; a single copy of a tumor-suppressor gene is sufficient to prevent cell proliferation. Therefore, extra copies of the tumor-suppressor gene will not lead to cancer.</p>
<aside class="tip c5 center v4" epub:type="tip" id="ben_9781319297145_jCc2EOuQ66" role="doc-tip" title="tip">
<p class="noindent" id="ben_9781319297145_bi2jFqMxvY"><strong class="important" id="ben_9781319297145_YtkMti2ArQ">Recall:</strong> An oncogene is an accelerator of cell division, while a tumor-suppressor gene is a brake.</p>
</aside>
</section>
</section>
<section class="learning-resources v1" epub:type="learning-resources" id="ben_9781319297145_VDOerZxDqI">
<header id="ben_9781319297145_OoCEnQ1ze0"><h3 class="title cap v1" epub:type="title" id="ben_9781319297145_GZ0T6pS08V">Important terms</h3></header>
<ul class="ul-no-mark" id="ben_9781319297145_ltZQL84nrg">
<li id="ben_9781319297145_tIHmJ9qfYd"><a class="crossref" href="pie_9781319216801_ch23_02.xhtml#ben_9781319297145_A1hMSCGhgH" id="ben_9781319297145_R3W0JvcuHC">malignant</a></li>
<li id="ben_9781319297145_G654WVZmtP"><a class="crossref" href="pie_9781319216801_ch23_02.xhtml#ben_9781319297145_vlNTcO7vOS" id="ben_9781319297145_ldHx7xSdJx">metastasis</a></li>
<li id="ben_9781319297145_zcBuES7yGP"><a class="crossref" href="pie_9781319216801_ch23_02.xhtml#ben_9781319297145_2yVq7H3hye" id="ben_9781319297145_v9fp9WddZo">clonal evolution</a></li>
<li id="ben_9781319297145_JEmJrdVYsM"><a class="crossref" href="pie_9781319216801_ch23_03.xhtml#ben_9781319297145_camPY3AyOJ" id="ben_9781319297145_dylKD45aZE">oncogene</a></li>
<li id="ben_9781319297145_o1fdTMySYK"><a class="crossref" href="pie_9781319216801_ch23_03.xhtml#ben_9781319297145_yLxUzSK4uq" id="ben_9781319297145_TfNVnupsC0">tumor-suppressor gene</a></li>
<li id="ben_9781319297145_wIFubxn5mF"><a class="crossref" href="pie_9781319216801_ch23_03.xhtml#ben_9781319297145_EjZOJxnqix" id="ben_9781319297145_rDNVAiZIpe">proto-oncogene</a></li>
<li id="ben_9781319297145_fDzisykZXI"><a class="crossref" href="pie_9781319216801_ch23_03.xhtml#ben_9781319297145_8U0Z9afSBk" id="ben_9781319297145_ec7zIfVkCW">loss of heterozygosity</a></li>
<li id="ben_9781319297145_Y36TTQ1sVE"><a class="crossref" href="pie_9781319216801_ch23_03.xhtml#ben_9781319297145_kXrfvpJPQ0" id="ben_9781319297145_4hCYlsJXCc">haploinsufficiency</a></li>
<li id="ben_9781319297145_MYHd0O5NMV"><a class="crossref" href="pie_9781319216801_ch23_03.xhtml#ben_9781319297145_GrwGumWuvZ" id="ben_9781319297145_XfG3PM7gYb">cyclin-dependent kinase (CDK)</a></li>
<li id="ben_9781319297145_6sESexaJOQ"><a class="crossref" href="pie_9781319216801_ch23_03.xhtml#ben_9781319297145_LR66o9ezGM" id="ben_9781319297145_6xhZJAVtsE">cyclin</a></li>
<li id="ben_9781319297145_lOgAhpa9I8"><a class="crossref" href="pie_9781319216801_ch23_03.xhtml#ben_9781319297145_xIQfBmcRip" id="ben_9781319297145_V2z1FUTpy3">signal-transduction pathway</a></li>
<li id="ben_9781319297145_eVzwo0ygTP"><a class="crossref" href="pie_9781319216801_ch23_03.xhtml#ben_9781319297145_Ar9ccoEi68" id="ben_9781319297145_reoTpSMEbp">driver</a></li>
<li id="ben_9781319297145_WBBfuDyPTp"><a class="crossref" href="pie_9781319216801_ch23_03.xhtml#ben_9781319297145_DvApCemHiZ" id="ben_9781319297145_g5uY0ZOjLR">passenger</a></li>
<li id="ben_9781319297145_rtPthgdfbn"><a class="crossref" href="pie_9781319216801_ch23_07.xhtml#ben_9781319297145_RCTZFFJQbe" id="ben_9781319297145_HPOJGcUTBl">human papillomavirus (HPV)</a></li>
</ul>
</section>
<section class="learning-resources v1" epub:type="learning-resources" id="ben_9781319297145_1iX38Vj0t0">
<header id="ben_9781319297145_E2sUx3lIyN"><h3 class="title cap v1" epub:type="title" id="ben_9781319297145_ZTe6h0RkRn">Answers to concept checks</h3></header>
<ol class="numbered-list" id="ben_9781319297145_Eui0pI6lUV">
<li class="answer noindent" epub:type="answer" id="ben_9781319297145_xNmLifXtLd">Retinoblastoma results from at least two separate genetic defects, both of which are necessary for cancer to develop. In sporadic cases, two successive mutations must occur in a single cell, which is unlikely, and therefore, the cancer typically affects only one eye. In people who have inherited one of the two required mutations, every cell contains this mutation, and so a single additional mutation is all that is required for cancer to develop. Given the millions of cells in each eye, there is a high probability that the second mutation will occur in at least one cell of each eye, producing tumors in both eyes and the inheritance of this type of retinoblastoma.</li>
<li class="answer noindent" epub:type="answer" id="ben_9781319297145_rMVnVIDqlH">Oncogenes have a stimulatory effect on cell proliferation. Mutations in oncogenes are usually dominant, because a mutation in a single copy of the gene is usually sufficient to produce a stimulatory effect. Tumor-suppressor genes inhibit cell proliferation. Mutations in tumor-suppressor genes are generally recessive, because both copies must be mutated to remove all inhibition.</li>
<li class="answer noindent" epub:type="answer" id="ben_9781319297145_DzIFVKj24o">d</li>
<li class="answer noindent" epub:type="answer" id="ben_9781319297145_wzncQM63oC">a</li>
<li class="answer noindent" epub:type="answer" id="ben_9781319297145_DY8dws9uEg">c</li>
<li class="answer noindent" epub:type="answer" id="ben_9781319297145_FgANSxFgp8">b</li>
<li class="answer noindent" epub:type="answer" id="ben_9781319297145_wuYWhrYi6J">d</li>
</ol>
</section>
</section>
</body>
</html>